Current and emerging treatment options to prevent renal failure due to autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Current and emerging treatment options to prevent renal failure due to autosomal dominant polycystic kidney disease

Published:2020-08-02 Issue:8 Volume:8 Page:285-302
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

K. Rangan Gopala¹²,Raghubanshi Aarya¹,Chaitarvornkit Alissa¹³,Chandra Ashley N.¹,Gardos Robert⁴,Munt Alexandra¹²,Read Mark N.⁵,Saravanabavan Sayanthooran¹,Zhang Jennifer Q.J.¹,Wong Annette T.Y.¹²

Affiliation:

1. Centre for Transplant and Renal Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia

2. Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District, Westmead, Australia

3. Faculty of Engineering, The University of Sydney, Camperdown, Australia

4. PKD Australia, Sydney, Australia

5. The School of Computer Science and the Westmead Initiative, The University of Sydney, Westmead, Australia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2020.1804859

Reference193 articles.

1. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia

2. Earlier Diagnosis of Autosomal Dominant Polycystic Kidney Disease: Importance of Family History and Implications for Cardiovascular and Renal Complications

3. Family History of Renal Disease Severity Predicts the Mutated Gene in ADPKD

4. Polycystic Kidney Disease without an Apparent Family History

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease;Kidney Medicine;2023-09

2. Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease;Nephrology;2021-08-09

3. Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease;Cells;2021-03-03